Literature DB >> 15274471

Breast asymmetry: a new vision of this malformation.

M G Onesti1, P Mezzana, A Martano, N Scuderi.   

Abstract

Breast asymmetry is defined as a difference of form, position or volume of the breast and is a pathology affecting over half of the female population (1, 4). Fortunately although it is very frequent, surgical correction is seldom necessary. The authors present the results of the surgical treatment of 73 patients affected with breast asymmetry and they describe the employment of a new instrumental method (SCAN-3D) that may be used both within the correction program and during the follow-up of the surgical treatment. The system involves the use of a laser to scan the surface to be acquired and by the subsequent analysis of the image produced by the overlap of itself with the area under examination, by utilising specific software, we retrieve information regarding both the morphologic and volumetric connections in all three dimensions. The employment of new research methods (Three-dimensional scanning) is an important aid to the aesthetic surgeon, as it allows the study of the mammary glands morpho-volumetric component in relation to the rest of the thorax. Moreover, in the future, the custom production of breast implants, made to measure, and perfectly adaptable to the deformity of each patient may be possible.

Entities:  

Mesh:

Year:  2004        PMID: 15274471

Source DB:  PubMed          Journal:  Acta Chir Plast        ISSN: 0001-5423


  2 in total

1.  Phobic memory and somatic vulnerabilities in anorexia nervosa: a necessary unity?

Authors:  Michael Myslobodsky
Journal:  Ann Gen Psychiatry       Date:  2005-09-06       Impact factor: 3.455

2.  Validation of the Vectra XT three-dimensional imaging system for measuring breast volume and symmetry following oncological reconstruction.

Authors:  Rachel L O'Connell; Komel Khabra; Jeffrey C Bamber; Nandita deSouza; Farid Meybodi; Peter A Barry; Jennifer E Rusby
Journal:  Breast Cancer Res Treat       Date:  2018-06-05       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.